Medication info

Bazevita Tablet

Prescription medicationTablet경구Expired
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
(주)비보존제약
Appearance
Pink oblong film-coated tablet
Packaging
28 tablets (28 tablets/PTP)
Approval status
Expired

MFDS item code 201900707 · Approved 2019.01.29

This product's status changed to Expired on 2024.01.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention of osteoporosis and spine fractures in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily regardless of meals.

Ingredients

Manufacturer
(주)비보존제약

Efficacy & effects

Prevention of osteoporosis and spine fractures in postmenopausal women

  • Osteoporosis in postmenopausal women
  • spinal fractures
View approved original text

This medication is used to treat and prevent osteoporosis in postmenopausal women. It is particularly effective in reducing the incidence of spinal fractures. However, the efficacy on non-vertebral fractures has not been clearly established, thus caution is needed. This medication can improve bone health and reduce fracture risk.

How to take

Adult dose

Take 1 tablet once daily regardless of meals.

Precautions

This medication may increase the risk of venous thromboembolism, such as deep vein thrombosis or pulmonary embolism. The risk is highest in the first year of treatment, so women at high risk for thrombosis should avoid taking this medication. This medication is intended for postmenopausal women only, and its safety has not been established in premenopausal women, hence it is not recommended. Additionally, while it does not induce endometrial hyperplasia, if uterine bleeding occurs during use, it is essential to consult a healthcare professional. The safety of this medication in breast cancer patients has not been sufficiently studied, so it is best not to use it for the prevention or treatment of breast cancer. This medication should not be administered to patients with a history of hypersensitivity or thrombosis, pregnant women or those who may become pregnant, breastfeeding women, patients with unexplained uterine bleeding, symptoms of endometrial cancer, hypercalcemia, hypercalciuria, or kidney stones. Also, this medication contains lactose, so individuals with certain genetic lactose intolerance should not take it. Patients with hypertriglyceridemia, renal or liver function impairment, limited movement, or those taking certain medications should use this medication cautiously and consult their physician if necessary. During treatment, symptoms such as flushing due to vasodilation or leg cramps may occur, and rare adverse reactions such as thrombosis, retinal vein thrombosis, dry mouth, and skin rashes have been reported. If any eye symptoms occur, notify healthcare personnel immediately. This medication is best taken with calcium supplements if calcium intake is insufficient and may require additional vitamin D supplementation for patients at high risk of vitamin D deficiency. Caution is needed while driving or operating machinery due to the potential for drowsiness or visual disturbances. In case of overdose, there are no specific antidotes, and symptomatic treatment should be provided. Excessive intake of vitamin D may increase blood calcium levels, causing various side effects, requiring blood tests and monitoring. This medication should be kept out of reach of children and stored in its original container to prevent misuse or deterioration of the drug's quality.

Side effects and when to seek care immediately

Serious side effects

  • Hives
  • retinal vein thrombosis
  • deep vein thrombosis
  • superficial thrombophlebitis
  • pulmonary embolism
  • severe allergic reactions
  • severe swelling
  • chest tightness
  • difficulty breathing
  • severe rash with fever
Show 12 more
  • blisters
  • skin peeling
  • pain in oral/ocular mucosa
  • yellowing of the skin or eyes
  • profound lethargy
  • sudden and severe headache
  • thunderclap headache
  • seizures
  • confusion of consciousness
  • visual disturbances
  • paralysis
  • markedly reduced urine output

Mild side effects

Drowsiness, flushing, leg cramps, dry mouth, rash, itching, muscle cramps, peripheral edema, increased serum triglycerides, elevated alanine aminotransferase (ALT), elevated aspartate aminotransferase (AST), decreased vision, blurred vision, photophobia, visual field loss, visual impairment, eye dryness, eyelid swelling, eyelid twitching, eye pain, eye swelling, vomiting, gastritis, belching, allergic reaction, chest discomfort, leg pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Pink oblong film-coated tablet

Package unit

28 tablets (28 tablets/PTP)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.